Sai Life Sciences Limited (NSE:SAILIFE)
India
· Delayed Price · Currency is INR 764.45
+15.55 (2.08%)
At close: Jun 27, 2025, 3:30 PM IST
Sai Life Sciences Revenue
In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B INR with 15.66% growth. Sai Life Sciences had revenue of 5.80B in the quarter ending March 31, 2025, with 31.94% growth.
Revenue
16.95B
Revenue Growth
+15.66%
P/S Ratio
9.09
Revenue / Employee
5.41M
Employees
2,845
Market Cap
153.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Mankind Pharma | 122.07B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.83B |